Background The burden of malaria infection in sub-Saharan Africa among school-aged
children aged 5–15 years is underappreciated and represents an important source of …

Malaria, caused mostly by Plasmodium falciparum and P. vivax, remains one of the most
important infectious diseases in the world. Antimalarial drug toxicity is one side of the risk …

Primaquine is the only available drug for preventing relapse of malaria, and confusion
surrounds its use. This review examines the wide range of clinical applications of …

Primaquine phosphate has been used for preventing relapse of Plasmodium vivax and P.
ovale malaria since the early 1950s, based on its ability to kill latent (hypnozoite) and …

Doxycycline, a synthetically derived tetracycline, is a partially efficacious causal prophylactic
(liver stage of Plasmodium) drug and a slow acting blood schizontocidal agent highly …

The gravity of the threat posed by vivax malaria to public health has been poorly
appreciated. The widely held misperception of Plasmodium vivax as being relatively …

Practice of Travel Medicine: Guidelines by the Infectious Diseases Society of America | Clinical
Infectious Diseases | Oxford Academic Skip to Main Content Advertisement Oxford Academic …

Malaria, a parasite vector-borne disease, is one of the greatest health threats in tropical
regions, despite the availability of malaria chemoprophylaxis. The emergence and rapid …

Background In malaria endemic areas, pre‐school children are at high risk of severe and
repeated malaria illness. One possible public health strategy, known as Intermittent …

Objective To compare the tolerability of malaria chemoprophylaxis regimens in non-immune
travellers. Design Randomised, double blind, study with placebo run-in phase. Setting …